See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2018_Viridian_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc.\DE
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 50,000 |
| 2 | AssetsCurrent | 51,868,000 |
| 3 | PropertyPlantAndEquipment | 563,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 10,074,000 |
| 6 | LiabilitiesCurrent | 3,897,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 10,912,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 19,623,000 |
| 16 | remainder_Expenses | 383,000 |
| 17 | remainder_Revenues | 4,003,000 |
| 18 | remainder_NetIncome | 403,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 52,481,000 |
| 1 | Liabilities | 13,971,000 |
| 2 | Expenses | 30,918,000 |
| 3 | Revenues | 4,003,000 |
| 4 | StockholdersEquity | 38,510,000 |
| 5 | NetIncome | -26,512,000 |
| 6 | ComprehensiveNetIncome | -26,512,000 |
| 7 | BaseVar | 56,716,460 |
| 8 | EconomicCapitalRatio | 0.898 |
Edgar->Model Mapping
Feature Distribution
Change over Time
